Trial Type: Melanoma, Skin

LS-P-DANCE
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants With Unresectable or Metastatic Melanoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Melanoma, Skin, Skin
Contact: Constantinou, Maria
mconstantinou@BrownHealth.org
LS-P-IGNYTE-3
Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician’s Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment [IGNYTE-3]
Protocol Status: OPEN TO ACCRUAL
Trial Type: Melanoma, Skin, Skin
Contact: Constantinou, Maria
mconstantinou@BrownHealth.org
BH-P-EARTH
A Phase 1b/2a Multi-Center, Dose Escalation and Reference Regimen-Controlled, Multi-Cohort Study to Determine the Safety and Efficacy of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy in Patients With Locally Advanced or Metastatic Cancers Following One or More Prior Therapies
Protocol Status: OPEN TO ACCRUAL
Trial Type: Gastrointestinal, Liver, Melanoma, Skin
Contact: Hadfield, Matthew
mhadfield@brownhealth.org